Menu
GWAS Study

Salt-inducible kinase 3, SIK3, is a new gene associated with hearing.

Wolber LE, Girotto G, Buniello A et al.

25060954 PubMed ID
GWAS Study Type
4939 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WL
Wolber LE
GG
Girotto G
BA
Buniello A
VD
Vuckovic D
PN
Pirastu N
LB
Lorente-Cánovas B
RI
Rudan I
HC
Hayward C
PO
Polasek O
CM
Ciullo M
MM
Mangino M
SC
Steves C
CM
Concas MP
CM
Cocca M
ST
Spector TD
GP
Gasparini P
SK
Steel KP
WF
Williams FM
Chapter II

Abstract

Summary of the research findings

Hearing function is known to be heritable, but few significant and reproducible associations of genetic variants have been identified to date in the adult population. In this study, genome-wide association results of hearing function from the G-EAR consortium and TwinsUK were used for meta-analysis. Hearing ability in eight population samples of Northern and Southern European ancestry (n = 4591) and the Silk Road (n = 348) was measured using pure-tone audiometry and summarized using principal component (PC) analysis. Genome-wide association analyses for PC1-3 were conducted separately in each sample assuming an additive model adjusted for age, sex and relatedness of subjects. Meta-analysis was performed using 2.3 million single-nucleotide polymorphisms (SNPs) tested against each of the three PCs of hearing ability in 4939 individuals. A single SNP lying in intron 6 of the salt-inducible kinase 3 (SIK3) gene was found to be associated with hearing PC2 (P = 3.7×10(-8)) and further supported by whole-genome sequence in a subset. To determine the relevance of this gene in the ear, expression of the Sik3 protein was studied in mouse cochlea of different ages. Sik3 was expressed in murine hair cells during early development and in cells of the spiral ganglion during early development and adulthood. Our results suggest a developmental role of Sik3 in hearing and may be required for the maintenance of adult auditory function.

1,022 European ancestry individuals, 280 Carlantino (founder/genetic isolate) individuals, 1,097 Friuli Venezia Giulia (founder/genetic isolate) individuals, 804 Korcula (founder/genetic isolate) individuals, 497 Split (founder/genetic isolate) individuals, 421 Cilento (founder/genetic isolate) individuals, 470 Talana (founder/genetic isolate) individuals, 348 Silk Road individuals

Chapter III

Study Statistics

Key metrics and study information

4939
Total Participants
GWAS
Study Type
No
Replicated
Other, European
Ancestry
Kazakhstan, Georgia, Azerbaijan, Tajikistan, Uzbekistan, Italy, U.K., Croatia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.